Epidemiology of invasive candidiasis
The DOI matches its Crossref record; 211 of the 212 references it cites were found in a registry or an index.
Abstract
Purpose of review This review covers candidaemia in numbers, susceptibility issues, host groups, risk factors and outcome. Recent findings The incidence of candidaemia has increased over the last decades. Candida glabrata is particularly common in the northern hemisphere and with increasing age whilst the opposite is true for C. parapsilosis, C. glabrata, C. krusei and a number of emerging species are not fully susceptible to azoles. C. parapsilosis and C. guilliermondii are not fully susceptible to echinocandins. Increasing rates of C. parapsilosis have been observed at centres with a high use of echinocandins, and outcome for this species is not superior comparing echinocandins with fluconazole. Acquired azole resistance has recently been described in as many as a third of 19% resistant isolates and echinocandin resistance has emerged and been detected as early as day 12 of echinocandin therapy. ICU stay and abdominal surgery are among the most important risk factors. Outcome is dependent on species involved, timing, dosing and choice of therapy and management of the primary focus of infection. However, host factors are dominating predictors of mortality in recent studies of ICU candidiasis. Summary The changing epidemiology highlights the need for close monitoring of local incidence, species distribution and susceptibility in order to optimize therapy and outcome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Comparisons of the incidence across countries is difficult as recent local epidemiological data was only available for 20 of the countries and the others used an incidence of 5 per 100,000 cases for their estimations [46].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [46]
In the citing paper
“Specifically, C. glabrata has become an important pathogen in North America, Europe (with the exception of Spain), and Australia, whereas C. parapsilosis is the dominant non-albicans species in South America, Japan, and Spain [8,9,10].”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [9]
Citations
Cites
Guidelines for the Prevention of Intravascular Catheter-related Infections
O'Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir257 · Cited by 4,699
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Vincent, J.-L. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,618
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Guidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286
Garey, K. W., Rege, M., Pai, M. P., Mingo, D. E., Suda, K. J., Turpin, R. S., & Bearden, D. T. (2006) · Clinical Infectious Diseases · doi:10.1086/504810 · Cited by 1,171
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
Research works printed but not linked: 3
- Hsin-Yun, 2010, Int J Antimicrob Agents, 353, 211
- Pfaller, 2007, J Invasive Fungal Infect, 1, 74
- Oxman, 2010, hemother, 65, 1460
Cited by
Items 201–300 of 377
The critical role of Dectin-1 in host controlling systemic Candida krusei infection.
Chen, S. M., Zou, Z., Qiu, X. R., Hou, W.-T., Zhang, Y., Fang, W. Y., Chen, Y. L., Wang, Y. D., Jiang, Y. Y., Shen, H., et al. (2019) · Europe PMC (PubMed Central) · Cited by 21
Li, R., YAN, X.-H., LU, Y.-B., LU, Y.-L., Zhang, H., Chen, S., Liu, S., & Lu, Z. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2731 · Cited by 16
Li, R., Zhang, L., Zhang, H., Yi, Y., Wang, L., Chen, L., & Zhang, L. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4290 · Cited by 17
Taj‐Aldeen, S. J., Salah, H., Perez, W. B., Almaslamani, M., Motyl, M. R., AbdulWahab, A., Healey, K. R., & Perlin, D. S. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00214-18 · Cited by 17
Torulopsis glabrata an emerging yeast pathogen in cancer patients
Krcmery, V. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(98)00066-1 · Cited by 15
Zaragoza, R., Llinares, P., Maseda, E., Ferrer, R., & Rodríguez, A. H. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.05.006 · Cited by 14
Stoia, D., Sio, L. D., Petronella, F., & Focşan, M. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.116243 · Cited by 17
Epidemiological patterns of candidaemia: A comprehensive analysis over a decade
Ferngren, G., Yu, D. C., Ünalan-Altıntop, T., Dinnétz, P., & Özenci, V. (2024) · Mycoses · doi:10.1111/myc.13729 · Cited by 19
First Report of Candida auris Spondylodiscitis in Oman: A Rare Presentation
Supreeth, S., Ghafri, K. A. A., Jayachandra, R. K., & Balushi, Z. Y. A. (2019) · World Neurosurgery · doi:10.1016/j.wneu.2019.09.021 · Cited by 16
Alvarez-Rueda, N., Rouges, C., Touahri, A., Misme‐Aucouturier, B., Albassier, M., & Pape, P. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-63344-6 · Cited by 17
Xiao, G., Liao, W., Zhang, Y., Luo, X., Zhang, C., Li, G., Yang, Y., & Xu, Y. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05291-1 · Cited by 22
Serious fungal diseases in Democratic Republic of Congo – Incidence and prevalence estimates
Kamwiziku, G. K., Makangara-Cigolo, J.-C., Orefuwa, E., & Denning, D. W. (2021) · Mycoses · doi:10.1111/myc.13339 · Cited by 16
Wang, B., He, X., Lü, F., Li, Y., Wang, Y., Zhang, M., Huang, Y., & Xia, J. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.779590 · Cited by 18
Candidaemia in a Polish tertiary paediatric hospital, 2000 to 2010
Dzierżanowska‐Fangrat, K., Romanowska, E., Gryniewicz–Kwiatkowska, O., Migdał, M., Witulska, K., Ryżko, J., Kaliciński, P., Książyk, J., Nadkowska, P., & Dzierzanowska, D. (2013) · Mycoses · doi:10.1111/myc.12107 · Cited by 17
Hii, I.-M., Liu, C.-E., Lee, Y.-L., Liu, W., Wu, P.-F., Hsieh, M.-H., Ho, M., Chen, Y., & Wang, F. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s184884 · Cited by 15
Antifungal Properties of Nerolidol-Containing Liposomes in Association with Fluconazole
Bezerra, C. F., Júnior, J. G. D. A. S., Honorato, R. D. L., dos Santos, A. T. L., da Silva, J. C. P., da Silva, T. G., Leal, A. L. A. B., de Freitas, T. S., Vieira, T. A. T., Rocha, J. E., et al. (2020) · Membranes · doi:10.3390/membranes10090194 · Cited by 16
Candidaemia in Central Slovenia: A 12‐year retrospective survey
Matos, T., Zupanc, T. L., Škofljanec, A., Jazbec, A., Matos, E., Vodičar, P. M., Germ, J., Ciglar, T., Tomazin, R., Kofol, R., et al. (2021) · Mycoses · doi:10.1111/myc.13278 · Cited by 15
In Vitro Activities of Six Antifungal Drugs Against Candida glabrata Isolates: An Emerging Pathogen
Amirrajab, N., Badali, H., Didehdar, M., Afsarian, M. H., Mohammadi, R., Lotfi, N., & Shokohi, T. (2016) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.36638 · Cited by 15
Radić, M., Goić-Barišić, I., Novak, A., Rubić, Ž., & Tonkić, M. (2016) · Medical Mycology · doi:10.1093/mmy/myw012 · Cited by 16
Treatment Principles for Candida and Cryptococcus
Whitney, L., & Bicanic, T. A. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024158 · Cited by 17
An Estimate of the Burden of Fungal Disease in Norway
Nordøy, I., Hesstvedt, L., Andersen, C. T., Mylvaganam, H., Kols, N. I., Falch, B. M., Tofteland, S., Müller, F., & Denning, D. W. (2018) · Journal of Fungi · doi:10.3390/jof4010029 · Cited by 13
Epidémiologie des candidoses invasives
Toubas, D. (2013) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(13)71944-0 · Cited by 19
The burden of serious fungal infections in Sierra Leone: a national estimate
Lakoh, S., Orefuwa, E., Kamara, M. N., Jiba, D. F., Kamara, J. B., Kpaka, S., & Denning, D. W. (2021) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361211027996 · Cited by 13
Nguni, T. L., Abrantes, P. M. D. S., McArthur, C. P., Klaasen, J. A., & Fielding, B. C. (2021) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2021.100503 · Cited by 18
An Antibody Reactivity-Based Assay for Diagnosis of Invasive Candidiasis Using Protein Array
Ardizzoni, A., Posteraro, B., Baschieri, M. C., Bugli, F., Sáez‐Rosón, A., Manca, L., Cacaci, M., Sterbini, F. P., de Waure, C., Sevilla, M.-J., et al. (2014) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201402700310 · Cited by 14
Boattini, M., Pinto, M. F., Christaki, E., Fasciana, T., Falces‐Romero, I., Tofarides, A. G., Bianco, G., Cendejas‐Bueno, E., Tricoli, M. R., Tsiolakkis, G., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11030560 · Cited by 13
Identification of potential markers of elevated anticandidal activity of propolis extracts
Bollin, P., Kuś, P. M., Okińczyc, P., Dijck, P. V., & Szweda, P. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119799 · Cited by 13
Zhang, J., Gong, H., Liao, M., Li, Z., Schweins, R., Penny, J. I., & Lu, J. R. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2021.09.170 · Cited by 14
Qiao, J., Gao, P., Jiang, X., & Fang, H. (2013) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-12-37 · Cited by 13
Clinical predictors of candidemia in medical non-neutropenic, non-ICU patients. The CaMed score
Ruiz‐Ruigómez, M., Dueñas, C., Hernandez, C., García, D. V., Coronado-Álvarez, N. M., Portillo-Tuñón, V., Cardozo, C., Muñoz‐Medina, L., Cabo-Magadán, R., Luna, J. D. D., et al. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13275 · Cited by 14
White, M. G., Piccirillo, S., Dusevich, V., Law, D. J., Kapros, T., & Honigberg, S. M. (2011) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2010.00712.x · Cited by 13
The Acutely Ill Patient with Fever and Rash
Weber, D. J., Cohen, M. S., & Rutala, W. A. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00057-6 · Cited by 14
Jan, H.-E., Lo, C.-L., Lee, J., Li, M.-C., Lin, W.-L., Ko, W., & Lee, N. (2023) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2023.08.014 · Cited by 13
Conlon, J. M. (2012) · ACS symposium series · doi:10.1021/bk-2012-1095.ch003 · Cited by 13
Protective Effects of cis-2-Dodecenoic Acid in an Experimental Mouse Model of Vaginal Candidiasis.
Yang, D., Zhang, Y. Q., Hu, Y. L., Weng, L. X., Zeng, G., & Wang, L. H. (2018) · PubMed · doi:10.3967/bes2018.109 · Cited by 11
Current burden of serious fungal infections in Republic of Congo
Amona, F. M., Denning, D. W., Moukassa, D., & Hennequin, C. (2020) · Mycoses · doi:10.1111/myc.13075 · Cited by 15
Current situation of fungal diseases in Eritrea
Werkneh, S., Orefuwa, E., & Denning, D. W. (2022) · Mycoses · doi:10.1111/myc.13474 · Cited by 8
A Recent Report on ‘Plants with Anti-Candida Properties’
Kumar, D., Ayesha, A., Jha, M., Gautam, P., Joshi, H. N., & Kumar, N. (2020) · International Journal of Current Research and Review · doi:10.31782/ijcrr.2020.12186 · Cited by 10
Rana, A., Gupta, N., & Thakur, A. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.101017 · Cited by 11
Distribution and antifungal susceptibility of yeasts isolates from intensive care unit patients
Hrabovský, V., Takáčová, V., Schréterová, E., Pastvová, L., Hrabovská, Z., Čurová, K., & Siegfried, L. (2017) · Folia Microbiologica · doi:10.1007/s12223-017-0525-8 · Cited by 13
Koehler, F. C., Cornely, O. A., Wisplinghoff, H., Chang, D., Richter, A., & Koehler, P. A. (2017) · Mycoses · doi:10.1111/myc.12696 · Cited by 11
Factors influencing outcomes in candidemia: A retrospective study of patients in a Swedish county
Klingspor, H. T., & Hällgren, A. (2024) · Mycoses · doi:10.1111/myc.13758 · Cited by 9
Asensio, Á., Múñez, E., Cantero, M., & Ramos, A. (2015) · American Journal of Infection Control · doi:10.1016/j.ajic.2015.04.207 · Cited by 9
Stable Redox-Cycling Nitroxide Tempol Has Antifungal and Immune-Modulatory Properties
Hosseinzadeh, A., Stylianou, M., Lopes, J. P., Müller, D. C., Häggman, A., Holmberg, S. M., Grumaz, C., Johansson, A. F., Sohn, K., Dieterich, C., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01843 · Cited by 10
Beredaki, M.-I., Georgiou, P., Siopi, M., Kanioura, L., Arendrup, M. C., Mouton, J. W., & Meletiadis, J. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz425 · Cited by 10
Self-citationJi, L., Zhou, A., Yu, X., Dong, Z., Zhao, H., Xue, H., & Wu, W. (2020) · The Journal of Antibiotics · doi:10.1038/s41429-020-0283-8 · Cited by 9
Human Fungal Infections in Kuwait—Burden and Diagnostic Gaps
Alfouzan, W. A., Al-Wathiqi, F., Altawalah, H., Asadzadeh, M., Khan, Z., & Denning, D. W. (2020) · Journal of Fungi · doi:10.3390/jof6040306 · Cited by 9
Gao, Y., Tang, M., Li, Y., Niu, X., Li, J., Fu, C., Wang, Z., Liu, J., Song, B., Chen, H., et al. (2022) · PeerJ · doi:10.7717/peerj.13594 · Cited by 9
Update on the Evolving Role of MALDI-TOF MS for Laboratory Diagnosis of Fungal Infections
Vermeulen, E., Verhaegen, J., Indevuyst, C., & Lagrou, K. (2012) · Current Fungal Infection Reports · doi:10.1007/s12281-012-0093-y · Cited by 9
Sarode, N., Davis, S. E., Tams, R. N., & Reynolds, T. B. (2014) · G3 Genes Genomes Genetics · doi:10.1534/g3.113.006361 · Cited by 12
Carveoylphenols and Their Antifungal Potential against Pathogenic Yeasts
Montenegro, I., Mellado, M., Russo, A., Said, B., Besoain, X. A., Godoy, P., Werner, E., Caro, N., & Madrid, A. (2019) · Antibiotics · doi:10.3390/antibiotics8040185 · Cited by 10
Correlation Between Drug Resistance and Virulence of Candida Isolates from Patients with Candidiasis
Yang, Z., Zhang, F., Li, D., Wang, S., Pang, Z., Chen, L., Li, R., & Shi, D. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s387675 · Cited by 8
Microsatellite Genotyping of Candida parapsilosis Clinical Isolates
Badali, H., Rezaie, S., Meis, J. F. G. M., Afshari, S. A. K., Modiri, M., Hagen, F., Moazeni, M., Mohammadi, R., & Khodavaisy, S. (2017) · Current Medical Mycology · doi:10.29252/cmm.3.4.15 · Cited by 10
Burden of serious fungal infections in Honduras
Higuita, N. I. A., Varela, D., & Denning, D. W. (2022) · Mycoses · doi:10.1111/myc.13432 · Cited by 9
Estimated Incidence and Prevalence of Serious Fungal Infections in Morocco
Lmimouni, B., Hennequin, C., Penney, R. O. S., & Denning, D. W. (2022) · Journal of Fungi · doi:10.3390/jof8040414 · Cited by 11
Mazari, W., Boucherit‐Otmani, Z., & Boucherit, K. (2014) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2014.10.027 · Cited by 9
Zand, F., Mohsen, Davarpanah, M. A., Masjedi, M., Nikandish, R., Amanati, A., Afarid, M., Nafarieh, L., & Nami, M. (2016) · Bioscience Biotechnology Research Communications · doi:10.21786/bbrc/9.3/6 · Cited by 7
Estimated burden of serious fungal infections in Togo
Dorkenoo, A. M., Adjetey‐Toglozombio, A. K., Ocansey, B. K., Sossou, E., Lack, F. A., & Denning, D. W. (2021) · Mycoses · doi:10.1111/myc.13377 · Cited by 9
Edlind, T., & Katiyar, S. K. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00721-22 · Cited by 8
Invasive Fungal Infections: The Early Killer after Liver Transplantation
Breitkopf, R., Treml, B., Bukumirić, Z., Innerhofer, N., Fodor, M., & Rajšić, S. (2023) · Journal of Fungi · doi:10.3390/jof9060655 · Cited by 8
Wang, L., Tong, Z., Wang, Z., Xu, L., Wu, Y., Liu, Y., & Wu, L. (2013) · Medical Mycology · doi:10.3109/13693786.2013.805441 · Cited by 9
The Role of HMGB1 in Invasive Candida albicans Infection
Wang, J., Wu, C., Wang, Y., Chen, C., Cheng, J., Rao, X.-L., & Sun, H. (2021) · Mycopathologia · doi:10.1007/s11046-021-00595-5 · Cited by 7
Azobenzene derivatives with activity against drug‐resistant Candida albicans and Candida auris
Raschig, M., Ramírez-Zavala, B., Wiest, J. M., Saedtler, M., Gutmann, M., Holzgrabe, U., Morschhäuser, J., & Meinel, L. (2022) · Archiv der Pharmazie · doi:10.1002/ardp.202200463 · Cited by 6
Chandrika, K. V. S. M., & Prathyusha, V. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2241102 · Cited by 7
Kannan, K. P., & Girija, A. S. S. (2024) · Brazilian Journal of Microbiology · doi:10.1007/s42770-024-01469-w · Cited by 7
Sikwewa, K., Simusika, P., Mumbula, E. M., Mwenya, D., Mandona, C., & Mulundu, G. (2023) · African Health Sciences · doi:10.4314/ahs.v23i3.58 · Cited by 6
Serrano, R., Gimeno, A., Plumed, L., Pemán, J., Álvarez, B., Plazas, J., & Caturla, J. (2012) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2012.06.003 · Cited by 9
Kumar, A., Roy, P., Rai, G., Das, S., & Ansari, M. A. (2017) · Indian Journal of Medical Specialities · doi:10.1016/j.injms.2017.06.001 · Cited by 6
OCCURRENCE OF CANDIDA SPP. IN HEALTHY ORAL MICROBIOTA
Kimsa, Ł., & Tokarska-Rodak, M. (2020) · Health Problems of Civilization · doi:10.5114/hpc.2020.94132 · Cited by 6
Recent changes in candidemia trends in a tertiary hospital (2011–2018)
Piqueras, A. I., Rubio, T. T., Medina, E. M. L., Gimeno, A., Modesto, V., Cantón, E., & Pemán, J. (2020) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2020.09.005 · Cited by 7
Burhannuddin, B., Karta, I. W., Tresnanda, B., Putra, I. G. N. D., Darmada, I. P. A., Pradnyadhita, I. I. D. A., Gunawan, I. W. B. A., & Ariawan, I. M. B. (2017) · JST (Jurnal Sains dan Teknologi) · doi:10.23887/jst-undiksha.v6i2.10535 · Cited by 10
In vitro activity of dihydropyrazole derivatives against Candida species
Abdelrahmman, K., El‐Behairy, M. F., Alsherbiny, M. A., & Mazeed, T. E.-S. (2017) · Bulletin of Faculty of Pharmacy Cairo University · doi:10.1016/j.bfopcu.2017.11.002 · Cited by 6
Novel High-Throughput Screening Method for Identification of Fungal Dimorphism Blockers
Stylianou, M., Uvell, H., Lopes, J. P., Enquist, P., Elofsson, M., & Urban, C. F. (2014) · SLAS DISCOVERY · doi:10.1177/1087057114552954 · Cited by 6
Epidemiology of Candidemia at a University Hospital in Colombia, 2008-2014
Correa, J. E. B., Valderrama, M. G. C., Alvernia, D. M. R., Mora, J. A., Figueroa, L. F. A., Malagón, M. N. R., & Herazo, J. R. G. (2018) · Universitas Médica · doi:10.11144/javeriana.umed60-1.cand · Cited by 9
Update on Antifungal Resistance and its Clinical Impact
Posteraro, B., Posteraro, P., & Sanguinetti, M. (2013) · Current Fungal Infection Reports · doi:10.1007/s12281-013-0143-0 · Cited by 5
Mnichowska-Polanowska, M., Adamowicz, M., Wojciechowska‐Koszko, I., Kisiel, A., Wojciuk, B., Jarosz, K., & Dołęgowska, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076541 · Cited by 6
Biofilms on urban aquatic plastic pollution as a reservoir for pathogenic yeasts
Baker, T., Bester, A., Sebolai, O. M., Albertyn, J., & Pohl, C. H. (2024) · Journal of Water and Health · doi:10.2166/wh.2024.133 · Cited by 5
Moncada, P. A., Cándelo, K. D., Sierra‐Ruiz, M., Rosso, F., Martínez, L. F., Paz, D., Pacheco, R., & Cuartas, M. A. (2020) · Infectio · doi:10.22354/in.v24i3.858 · Cited by 9
Candidiasis invasora: un enfoque a la infección en el sistema nervioso central
Vigezzi, C., Riera, F. O., Rodríguez, E., Icely, P. A., Miró, M. S., Figueredo, C. M., Caeiro, J. P., & Sotomayor, C. E. (2020) · Revista Argentina de Microbiología · doi:10.1016/j.ram.2020.06.003 · Cited by 10
Seyedmousavi, S., İlkit, M., Durdu, M., Ergin, Ç., Polat, S. H., Melchers, W. J. G., & Verweij, P. E. (2015) · Türk Mikrobiyoloji Cemiyeti Dergisi · doi:10.5222/tmcd.2015.001 · Cited by 5
The Burden of Serious Fungal Infections in Kyrgyzstan
Turdumambetova, G. K., Osmanov, A., & Denning, D. W. (2019) · Journal of Fungi · doi:10.3390/jof5030066 · Cited by 6
Vahedi‐Shahandashti, R., Moroder, E., & Lass‐Flörl, C. (2025) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00241-25 · Cited by 5
Göğer, G., ÇEVİK, E., VARNALI, A., Yaylacı, Ö. K., Uma, M., & Özek, G. (2023) · Trakya University Journal of Natural Sciences · doi:10.23902/trkjnat.1322140 · Cited by 4
Zaragoza, R., Llinares, P., Maseda, E., Ferrer, R., & Rodríguez, A. H. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.05.005 · Cited by 4
Estimated burden of fungal infections in Panama
Rodriguez-Vargas, C. M., Alastruey‐Izquierdo, A., Denning, D. W., & Araúz, A. B. (2024) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2024.101466 · Cited by 6
Xu, Z.-C., Ma, X.-R., Zhang, L., Chen, H., Qing, D.-M., Li, R., Ye, R., & Wang, R. (2024) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2024.112522 · Cited by 4
Antifungal Efficacy of Plant Essential Oils Against Candida, Aspergillus and Cryptococcus Species
Kumari, K. M. U., Imam, M. W., & Luqman, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-5165-5_5 · Cited by 4
Influence of a plasma jet on the viability of Candida albicans
Moravský, L., Klas, M., Machová, E., Pisklová, K., & Matejčík, Š. (2014) · Open Chemistry · doi:10.1515/chem-2015-0028 · Cited by 4
Sarenje, K., Lukwesa‐Musyani, C., Mwansa, J. C. L., Samutela, M., Kalonda, A., Kaile, T., Mwaba, J., & Kwenda, G. (2017) · IOSR Journal of Pharmacy (IOSRPHR) · doi:10.9790/3013-0702010109 · Cited by 4
Updated estimated incidence and prevalence of serious fungal infections in Trinidad and Tobago
Edwards, R. J., Boyce, G., Alastruey‐Izquierdo, A., & Denning, D. W. (2021) · IJID Regions · doi:10.1016/j.ijregi.2021.09.007 · Cited by 4
Mortality Risk Factors for Invasive Candidiasis in Pediatric Intensive Care Unit
Korulmaz, A., Alakaya, M., Erdoğan, S., Arslanköylü, A. E., Özgür, D., & Otağ, Z. F. (2021) · Mikrobiyoloji Bulteni · doi:10.5578/mb.20219709 · Cited by 4
Şanlı, K., Komurcu, S. Z. M., & Şahin, A. S. (2021) · Dicle Medical Journal / Dicle Tip Dergisi · doi:10.5798/dicletip.1037792 · Cited by 4
An Atypical Source of Persistent Fungemia in the Intensive Care Unit
Wiggins, A. R., & Reddy, R. M. (2022) · American Journal of Case Reports · doi:10.12659/ajcr.936223 · Cited by 4
Biçer, M. (2023) · Archives of Microbiology · doi:10.1007/s00203-023-03744-0 · Cited by 6
Dudiuk, C., Theill, L., Gamarra, S. P., & García‐Effrón, G. (2017) · Current Fungal Infection Reports · doi:10.1007/s12281-017-0294-5 · Cited by 6
Recent trends in the development of bacterial and fungal vaccines
Mir, M. A., Usman, M., Qadri, H., & Aisha, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-96127-1.00003-6 · Cited by 5
Invasive candidiasis in critically ill patients
Kaaniche, F. M., Allela, R., Cherif, S., & Algia, N. B. (2016) · Trends in Anaesthesia and Critical Care · doi:10.1016/j.tacc.2016.11.002 · Cited by 7
Colombo, A. L., Guimarães, T., Camargo, L. F. A., Richtmann, R., Queiroz‐Telles, F., Salles, M. J. C., da Cunha, C. A., Shikanai‐Yasuda, M. A., Moretti, M. L., & Nucci, M. (2012) · The Brazilian Journal of Infectious Diseases · doi:10.1016/s1413-8670(12)70336-7 · Cited by 6
Ali, S., Collison, M., McNicholas, S., & McDermott, S. (2023) · Access Microbiology · doi:10.1099/acmi.0.000617.v4 · Cited by 3
Song, D., Liu, H., Huang, Y., Dongari‐Bagtzoglou, A. I., & Yu, L. (2023) · Analytical Letters · doi:10.1080/00032719.2023.2297301 · Cited by 3
Metadata
- Authors
- Arendrup, M. C.
- Affiliations
- Statens Serum Institut (DK)
- Corresponding author
- Arendrup, Maiken C
- ORCID
- Arendrup, Maiken C
- Venue
- Current Opinion in Critical Care
- Published
- 2010-10
- Volume
- 16
- Issue
- 5
- Pages
- 445-452
- ISSN
- 1070-5295 (ISSN-L)
- OpenAlex
- W2088977070
- Cited by
- 376
- References
- 212
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 12 · 2023: 15 · 2022: 14 · 2021: 24 · 2020: 30 · 2019: 25 · 2018: 35 · 2017: 27 · 2016: 24 · 2015: 33 · 2014: 27 · 2013: 35 · 2012: 32
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Critical Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Astellas Pharma
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Keywords
- invasive candidiasis, candidemia, Candida parapsilosis, Candida glabrata, Candida krusei, Candida guilliermondii, antifungal susceptibility, azole resistance, echinocandin resistance, fluconazole, risk factors, mortality, intensive care unit, abdominal surgery, antifungal therapy
- MeSH terms
- Disease Susceptibility, Humans, Intensive Care Units, Species Specificity, Candidiasis, Invasive, Candidemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.